Mobile Trading

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : RetailingHouse : Private
BSE812.503.8 (+0.47 %)
PREV CLOSE ( ) 808.70
OPEN PRICE ( ) 792.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5415
TODAY'S LOW / HIGH ( )792.40 819.00
52 WK LOW / HIGH ( )603 1052.05
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)12.565.484.178.031425.40
   CEPS(Rs)33.4224.2419.4217.94675.81
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)143.22129.47122.44117.8915220.96
   Tax Rate(%)18.0310.71-6.2419.6933.64
Margin Ratios
   Core EBITDA Margin(%)8.096.516.087.547.32
   EBIT Margin(%)4.863.283.155.245.19
   Pre Tax Margin(%)2.951.291.023.083.04
   PAT Margin (%)2.411.151.082.472.01
   Cash Profit Margin (%)6.435.085.015.594.83
Performance Ratios
   ROA(%)4.732.271.864.514.31
   ROE(%)9.214.363.509.0710.51
   ROCE(%)18.2212.199.5616.5621.69
   Asset Turnover(x)1.961.981.721.832.14
   Sales/Fixed Asset(x)3.183.283.394.134.38
   Working Capital/Sales(x)4.915.474.603.576.16
Efficiency Ratios
   Fixed Capital/Sales(x)0.310.300.300.240.23
   Receivable days0.900.840.580.540.69
   Inventory Days78.7679.5281.2779.2881.18
   Payable days21.7121.3325.9824.1328.76
Valuation Parameters
   PER(x)60.48125.87156.11125.800.00
   PCE(x)22.7228.4433.5356.300.00
   Price/Book(x)5.305.335.328.570.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)1.421.441.643.220.01
   EV/Core EBITDA(x)15.8019.6922.8637.970.07
   EV/EBIT(x)28.8743.2951.3060.530.11
   EV/CE(x)5.015.135.024.630.01
   M Cap / Sales1.481.471.703.190.00
Growth Ratio
   Net Sales Growth(%)9.0923.4220.5923.136.92
   Core EBITDA Growth(%)34.2325.612.2527.7166.11
   EBIT Growth(%)61.5528.24-27.3823.63113.38
   PAT Growth(%)129.0930.88-47.1050.083417.89
   EPS Growth(%)129.2931.32-48.06-99.441441.40
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.100.20
   Current Ratio(x)3.032.813.112.922.14
   Quick Ratio(x)0.870.480.711.280.46
   Interest Cover(x)2.541.651.482.422.41
   Total Debt/Mcap(x)0.000.000.000.01

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.